Global $13.4 Billion Cannabidiol Market to 2028

DUBLIN, March 24, 2021 / PRNewswire / – The report “Cannabidiol Market Sizes, Stocks and Trends Analysis Report 2021-2028” has been added to the offering from ResearchAndMarkets.com.

The global cannabidiol market size is projected to reach $ 13.4 billion by 2028. The market is forecast to grow at an annual growth rate of 21.2% from 2021 to 2028.

Raising awareness of the health benefits of cannabidiol (CBD), changing consumer attitudes and attitudes toward CBD products are some of the key drivers in driving demand for these products. In addition, increasing demand for cannabidiol from various end-user industries such as food and beverages, personal care and cosmetic products, and pharmaceuticals is expected to trigger market growth.

The recent COVID-19 pandemic has affected many industries around the world, including the CBD industry. The effects of COVID-19 have led to disruptions in production processes. Due to strict quarantine measures around the world, the supply of products, including CBD products, is stagnating. Additionally, most of the retail stores are currently closed due to the pandemic. As such, the market could slow down amid the pandemic, but it could gain momentum in 2021 due to increasing demand for CBD-based products in the years to come.

In 2020, the hemp segment had the largest share of sales at $ 1.7 billion due to increased awareness of the health benefits of products infused with marijuana-derived cannabidiol. On the other hand, due to the increasing legalization of hemp in various countries, it is expected that hemp-derived CBD will have the fastest CAGR in the forecast period.

The Business to Business (B2B) segment had the largest share of sales in 2020 and is expected to show a lucrative growth rate in the forecast period. The growing demand for cannabidiol products in various sectors such as health and wellness, pharmaceuticals, food and additives, and cosmetics has increased the need for companies to source cannabidiol raw materials or precursors for their products in bulk. As a result, there are various growth opportunities in the cannabidiol wholesale business that are expected to drive the growth of this segment.

North America dominated the market in 2020 and is expected to continue its dominance over the forecast period. Favorable regulations, increasing awareness of CBD oil, growing consumer preference, and an increase in the number of manufacturers are factors that are expected to fuel market growth in the region.

Cannabidiol Market Report Highlights

North America had the largest share of sales in 2020 as more consumers turned to CBD oil and raised awareness of related products. Hemp CBD dominated the market in 2020 with $ 1.7 billion in sales due to its higher purity and potential health benefits The B2B segment had 2020 due to increasing demand and the increasing number of companies using cannabidiol as raw materials, the largest share of sales. In 2020, the medical segment had the largest share of sales due to the increasing use of cannabis derivatives for various medical purposes

Main topics covered:

Chapter 1 Methodology and Scope

Chapter 2 Summary

Chapter 3 CBD Market Variables, Trends, and Scope
3.1 Market Segmentation (Global Cannabidiol (CBD) Market)
3.2 Trade route for global cannabis extracts
3.3 Global demand and supply analysis for cannabis extracts
3.4 Mapping the penetration and growth prospects
3.5 Cannabis regulatory scenario by country
3.5.1 US
3.5.1.1 Cultivation / production
3.5.1.2 Legal status (CBD & THC)
3.5.1.3 Regulatory authorities involved
3.5.2 Canada
3.5.3 Germany
3.5.4 Italy
3.5.5 Croatia
3.5.6 Netherlands
3.5.7 Czech Republic
3.5.8 Poland
3.5.9 Switzerland
3.5.10 Australia
3.5.11 Israel
3.5.12 Uruguay
3.5.13 Colombia
3.5.14 Argentina
3.5.15 Chile
3.6 Market dynamics
3.6.1 Market driver analysis
3.6.1.1 Increasing legalization of cannabis-based CBD products
3.6.1.2 Increasing preference for cannabis extracts such as oils and tinctures
3.6.1.3 Increasing acceptance of CBD-based products for the treatment of various diseases
3.6.1.4 Increase in the number of retailers selling CBD-based products
3.6.2 Market Restriction Analysis
3.6.2.1 Strict government regulations
3.6.2.2 Lack of legalization programs in several Asian and African countries
3.6.2.3 High CBD costs in leading markets
3.6.3 Challenges for the industry
3.7 Cannabidiol (CBD) – Porter Analysis
3.8 Cannabidiol (CBD) – PESTEL analysis
3.9 Opportunity Analysis (2016-2020-2028)
3.10 Import / Export Scenario by Country
3.11 Analysis of the product acceptance pattern
3.12 Value chain analysis
3.12.1 Raw material trends
3.12.1.1 Market price development of raw material costs for biomass (for the processor)
3.12.1.2 Manufacturing trends
3.13 Average sales price of cannabidiol by country
3.14 Key End Users
3.14.1 US market scenario
3.15 COVID-19 impact analysis

Chapter 4 Cannabidiol (CBD) Market: Source Type Estimates and Trend Analysis
4.1 Cannabidiol (CBD) market size and forecasts and trend analysis by source, 2016-2028, (in MILLION USD)
4.1.1 Hemp
4.1.2 Marijuana

Chapter 5 Cannabidiol (CBD) Market: Distribution Channels Estimates and Trend Analysis
5.1 Cannabidiol (CBD) Market, by Distribution Channel Analysis
5.2 Business to Business (B2B)
5.3 Business to Consumer (B2C)
5.3.1 Hospital pharmacies
5.3.2 Online shops
5.3.3 Retail Stores

Chapter 6 Cannabidiol (CBD) Market: End Use Estimations and Trend Analysis
6.1 Cannabidiol (CBD) Market by End Use Analysis
6.2 Medicine
6.2.1 Chronic pain
6.2.2 Mental disorders
6.2.3 Cancer
6.2.4 Others
6.3 Personal use
6.4 Pharmaceutical
6.5 wellness
6.5.1 Food and drinks
6.5.2 Personal Care & Cosmetics
6.5.3 Nutraceuticals

Chapter 7 Cannabidiol (CBD) Market: Regional Estimates and Trend Analysis
7.1 Global Cannabidiol Market Share by Region, 2020 and 2028

Chapter 8 Competitive Landscape

Canopy Growth Corporation. Aphria, Inc. Aurora Cannabis Maricann, Inc. (Wayland Group Corporation) Tilray GW Pharmaceuticals, plc ABcann Medicinals, Inc. Organization Chart Holding, Inc. Tikun Olam The Cronos Group ENDOCA Isodiol International, Inc. MEDICAL MARIJUANA, INC. Cannoid, LLC Elixinol Folium Life Sciences NuLeaf Naturals, LLC Pharmahemp doo

Please visit https://www.researchandmarkets.com/r/7a2ib8 for more information on this report

Media contact:

Research and Markets
Laura Wood, senior manager
[email protected]

For EST office hours, call + 1-917-300-0470
For Toll Free US / CAN, call + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): + 353-1-481-1716

SOURCE RESEARCH and Markets

similar links

http://www.researchandmarkets.com